225 related articles for article (PubMed ID: 32221790)
21. Follicular fluid anti-Müllerian hormone: a predictive marker of fertilization capacity of MII oocytes.
Tramišak Milaković T; Panić Horvat L; Čavlović K; Smiljan Severinski N; Vlašić H; Vlastelić I; Ljiljak D; Radojčić Badovinac A
Arch Gynecol Obstet; 2015 Mar; 291(3):681-7. PubMed ID: 25205183
[TBL] [Abstract][Full Text] [Related]
22. Relationship between follicular volume and oocyte competence, blastocyst development and live-birth rate: optimal follicle size for oocyte retrieval.
Wirleitner B; Okhowat J; Vištejnová L; Králíčková M; Karlíková M; Vanderzwalmen P; Ectors F; Hradecký L; Schuff M; Murtinger M
Ultrasound Obstet Gynecol; 2018 Jan; 51(1):118-125. PubMed ID: 29134715
[TBL] [Abstract][Full Text] [Related]
23. Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders.
Moffat R; Hansali C; Schoetzau A; Ahler A; Gobrecht U; Beutler S; Raggi A; Sartorius G; De Geyter C
Hum Reprod; 2021 Mar; 36(4):987-997. PubMed ID: 33367742
[TBL] [Abstract][Full Text] [Related]
24. Lower follicular n-3 polyunsaturated fatty acid levels are associated with a better response to ovarian stimulation.
Ruiz-Sanz JI; Pérez-Ruiz I; Meijide S; Ferrando M; Larreategui Z; Ruiz-Larrea MB
J Assist Reprod Genet; 2019 Mar; 36(3):473-482. PubMed ID: 30547270
[TBL] [Abstract][Full Text] [Related]
25. Melatonin levels in follicular fluid as markers for IVF outcomes and predicting ovarian reserve.
Tong J; Sheng S; Sun Y; Li H; Li WP; Zhang C; Chen ZJ
Reproduction; 2017 Apr; 153(4):443-451. PubMed ID: 28062641
[TBL] [Abstract][Full Text] [Related]
26. Luteal phase stimulation versus follicular phase stimulation in poor ovarian responders: results of a randomized controlled trial.
Llácer J; Moliner B; Luque L; Bernabéu A; Lledó B; Castillo JC; Guerrero J; Ten J; Bernabéu R
Reprod Biol Endocrinol; 2020 Feb; 18(1):9. PubMed ID: 32033610
[TBL] [Abstract][Full Text] [Related]
27. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
Orvieto R
J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
[TBL] [Abstract][Full Text] [Related]
28. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.
Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G
Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834
[TBL] [Abstract][Full Text] [Related]
29. Flexible ovarian stimulation in a poor responder: a case report and literature review.
Xu B; Li Y
Reprod Biomed Online; 2013 Apr; 26(4):378-83. PubMed ID: 23497915
[TBL] [Abstract][Full Text] [Related]
30. Controlled ovulation of the dominant follicle using progestin in minimal stimulation in poor responders.
Chen Q; Wang Y; Sun L; Zhang S; Chai W; Hong Q; Long H; Wang L; Lyu Q; Kuang Y
Reprod Biol Endocrinol; 2017 Sep; 15(1):71. PubMed ID: 28870217
[TBL] [Abstract][Full Text] [Related]
31. Luteal phase ovarian stimulation for poor ovarian responders.
Zhang W; Wang M; Wang S; Bao H; Qu Q; Zhang N; Hao C
JBRA Assist Reprod; 2018 Sep; 22(3):193-198. PubMed ID: 29931967
[TBL] [Abstract][Full Text] [Related]
32. The follicular hormonal profile in low-responder patients undergoing unstimulated cycles: Is it hypoandrogenic?
de los Santos MJ; García-Laez V; Beltrán D; Labarta E; Zuzuarregui JL; Alamá P; Gámiz P; Crespo J; Bosch E; Pellicer A
Hum Reprod; 2013 Jan; 28(1):224-9. PubMed ID: 23019297
[TBL] [Abstract][Full Text] [Related]
33. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
Dai X; Wang Y; Yang H; Gao T; Yu C; Cao F; Xia X; Wu J; Zhou X; Chen L
Sci Rep; 2020 Nov; 10(1):19750. PubMed ID: 33184364
[TBL] [Abstract][Full Text] [Related]
34. Luteal granulosa cells from natural cycles are more capable of maintaining their viability, steroidogenic activity and LH receptor expression than those of stimulated IVF cycles.
Bildik G; Akin N; Seyhan A; Esmaeilian Y; Yakin K; Keles I; Balaban B; Ata B; Urman B; Oktem O
Hum Reprod; 2019 Feb; 34(2):345-355. PubMed ID: 30520979
[TBL] [Abstract][Full Text] [Related]
35. The integrity of cfDNA in follicular fluid and spent medium from embryo culture is associated with embryo grade in patients undergoing in vitro fertilization.
Pan M; Shi H; Liu Z; Dong J; Cai L; Ge Q
J Assist Reprod Genet; 2021 Dec; 38(12):3113-3124. PubMed ID: 34820723
[TBL] [Abstract][Full Text] [Related]
36. Follicular flushing increases the number of oocytes retrieved in poor ovarian responders undergoing in vitro fertilization: a retrospective cohort study.
Xiao Y; Wang Y; Wang M; Liu K
BMC Womens Health; 2018 Nov; 18(1):186. PubMed ID: 30445950
[TBL] [Abstract][Full Text] [Related]
37. Mitochondria-targeted therapy rescues development and quality of embryos derived from oocytes matured under oxidative stress conditions: a bovine in vitro model.
Marei WFA; Van den Bosch L; Pintelon I; Mohey-Elsaeed O; Bols PEJ; Leroy JLMR
Hum Reprod; 2019 Oct; 34(10):1984-1998. PubMed ID: 31625574
[TBL] [Abstract][Full Text] [Related]
38. Response to ovulation trigger is correlated to late follicular phase progesterone levels: A hypothesis explaining reduced reproductive outcomes caused by increased late follicular progesterone rise.
Friis Wang N; Skouby SO; Humaidan P; Andersen CY
Hum Reprod; 2019 May; 34(5):942-948. PubMed ID: 30927415
[TBL] [Abstract][Full Text] [Related]
39. Minimum ovarian stimulation involving combined clomiphene citrate and estradiol treatment for in vitro fertilization of Bologna-criteria poor ovarian responders.
Kuroda K; Kitade M; Kumakiri J; Jinushi M; Shinjo A; Ozaki R; Ikemoto Y; Katoh N; Takeda S
J Obstet Gynaecol Res; 2016 Feb; 42(2):178-83. PubMed ID: 26555576
[TBL] [Abstract][Full Text] [Related]
40. No advantage of fresh blastocyst versus cleavage stage embryo transfer in women under the age of 39: a randomized controlled study.
Levi-Setti PE; Cirillo F; Smeraldi A; Morenghi E; Mulazzani GEG; Albani E
J Assist Reprod Genet; 2018 Mar; 35(3):457-465. PubMed ID: 29168022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
